|
UniProt ID
Unique identifier for the protein in the UniProt database. Click to view detailed protein information.
|
O15047 |
| Protein name |
Histone-lysine N-methyltransferase SETD1A (EC 2.1.1.364) (Lysine N-methyltransferase 2F) (SET domain-containing protein 1A) (hSET1A) (Set1/Ash2 histone methyltransferase complex subunit SET1) |
| Protein function |
Histone methyltransferase that catalyzes methyl group transfer from S-adenosyl-L-methionine to the epsilon-amino group of 'Lys-4' of histone H3 (H3K4) via a non-processive mechanism (PubMed:12670868, PubMed:25561738). Part of chromatin remodelin |
| PDB |
3S8S
, 3UVN
, 4EWR
, 8ILY
|
| Family and domains |
Pfam
| Accession |
ID |
Position in sequence |
Description |
Type |
| PF00076 |
RRM_1 |
99 → 166 |
RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) |
Domain |
| PF11764 |
N-SET |
1425 → 1562 |
COMPASS (Complex proteins associated with Set1p) component N |
Domain |
| PF00856 |
SET |
1579 → 1685 |
SET domain |
Family |
|
| Sequence |
MDQEGGGDGQKAPSFQWRNYKLIVDPALDPALRRPSQKVYRYDGVHFSVNDSKYIPVEDL QDPRCHVRSKNRDFSLPVPKFKLDEFYIGQIPLKEVTFARLNDNVRETFLKDMCRKYGEV EEVEILLHPRTRKHLGLARVLFTSTRGAKETVKNLHLTSVMGNIIHAQLDIKGQQRMKYY ELIVNGSYTPQTVPTGGKALSEKFQGSGAATETAESRRRSSSDTAAYPAGTTAVGTPGNG TPCSQDTSFSSSRQDTPSSFGQFTPQSSQGTPYTSRGSTPYSQDSAYSSSTTSTSFKPRR SENSYQDAFSRRHFSASSASTTASTAIAATTAATASSSASSSSLSSSSSSSSSSSSSQFR SSDANYPAYYESWNRYQRHTSYPPRRATREEPPGAPFAENTAERFPPSYTSYLPPEPSRP TDQDYRPPASEAPPPEPPEPGGGGGGGGPSPEREEVRTSPRPASPARSGSPAPETTNESV PFAQHSSLDSRIEMLLKEQRSKFSFLASDTEEEEENSSMVLGARDTGSEVPSGSGHGPCT PPPAPANFEDVAPTGSGEPGATRESPKANGQNQASPCSSGDDMEISDDDRGGSPPPAPTP PQQPPPPPPPPPPPPPYLASLPLGYPPHQPAYLLPPRPDGPPPPEYPPPPPPPPHIYDFV NSLELMDRLGAQWGGMPMSFQMQTQMLTRLHQLRQGKGLIAASAGPPGGAFGEAFLPFPP PQEAAYGLPYALYAQGQEGRGAYSREAYHLPMPMAAEPLPSSSVSGEEARLPPREEAELA EGKTLPTAGTVGRVLAMLVQEMKSIMQRDLNRKMVENVAFGAFDQWWESKEEKAKPFQNA AKQQAKEEDKEKTKLKEPGLLSLVDWAKSGGTTGIEAFAFGSGLRGALRLPSFKVKRKEP SEISEASEEKRPRPSTPAEEDEDDPEQEKEAGEPGRPGTKPPKRDEERGKTQGKHRKSFA LDSEGEEASQESSSEKDEEDDEEDEEDEDREEAVDTTKKETEVSDGEDEESDSSSKCSLY ADSDGENDSTSDSESSSSSSSSSSSSSSSSSSSSSSSSESSSEDEEEEERPAALPSASPP PREVPVPTPAPVEVPVPERVAGSPVTPLPEQEASPARPAGPTEESPPSAPLRPPEPPAGP PAPAPRPDERPSSPIPLLPPPKKRRKTVSFSAIEVVPAPEPPPATPPQAKFPGPASRKAP RGVERTIRNLPLDHASLVKSWPEEVSRGGRSRAGGRGRLTEEEEAEPGTEVDLAVLADLA LTPARRGLPALPAVEDSEATETSDEAERPRPLLSHILLEHNYALAVKPTPPAPALRPPEP VPAPAALFSSPADEVLEAPEVVVAEAEEPKPQQLQQQREEGEEEGEEEGEEEEEESSDSS SSSDGEGALRRRSLRSHARRRRPPPPPPPPPPRAYEPRSEFEQMTILYDIWNSGLDSEDM SYLRLTYERLLQQTSGADWLNDTHWVHHTITNLTTPKRKRRPQDGPREHQTGSARSEGYY PISKKEKDKYLDVCPVSARQLEGVDTQGTNRVLSERRSEQRRLLSAIGTSAIMDSDLLKL NQLKFRKKKLRFGRSRIHEWGLFAMEPIAADEMVIEYVGQNIRQMVADMREKRYVQEGIG SSYLFRVDHDTIIDATKCGNLARFINHCCTPNCYAKVITIESQKKIVIYSKQPIGVDEEI TYDYKFPLEDNKIPCLCGTESCRGSLN
|
|
| Sequence length |
1707 |
| Interactions |
View interactions |
| Phenotype Name |
Clinical Significance |
dbSNP ID |
RCV Accession |
| Autism spectrum disorder |
Likely pathogenic |
rs2543876108 |
RCV003127372 |
| Epilepsy, early-onset, with or without developmental delay |
Likely pathogenic; Pathogenic |
rs2143509708, rs61744449, rs2543861155, rs2056158149, rs755127868, rs2056165149, rs2056100951, rs781482552, rs2056003750, rs2056118338 |
RCV002225059 RCV002289157 RCV004783056 RCV004783064 RCV001788230 RCV001034711 RCV001034712 RCV001034713 RCV001250554 RCV001254164 |
| Intellectual disability |
Likely pathogenic |
rs2056144779 |
RCV001257739 |
| Neurodevelopmental disorder |
Pathogenic |
rs2143491920 |
RCV002273265 |
| Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies |
Pathogenic |
rs2543874648 |
RCV003128089 |
| Neurodevelopmental disorder with speech impairment and dysmorphic facies |
Likely pathogenic; Pathogenic |
rs2056114867, rs2143514019, rs2143509708, rs2543831672, rs2543866311, rs2543909603, rs2543847896, rs2543859166, rs2543833500, rs2543908638, rs2543861155, rs2056158149, rs2543876266, rs2543862825, rs755127868, rs2056360507, rs2056124989, rs2056111688 View all (3 more) |
RCV001706797 RCV001814628 RCV002225059 RCV002287616 RCV002294587 RCV002468784 RCV002510552 RCV003140421 RCV003155649 RCV003314301 RCV004783056 RCV003444528 RCV003493275 RCV003985227 RCV001775121 RCV001261422 RCV001261423 RCV001261424 |
| Schizophrenia |
Pathogenic |
rs2056099559, rs869312829, rs869312830, rs770913157, rs869312832, rs869312831 |
RCV001801339 RCV000210278 RCV000210255 RCV000210257 RCV000210279 RCV000210263 |
| SETD1A-related disorder |
Likely pathogenic |
rs1567353500 |
RCV003420945 |
|
|
|
| Disease Name |
Relationship Type |
References |
| Apraxias |
Associate |
29463886, 36117209, 40225914 |
| Arthritis Psoriatic |
Associate |
20862685 |
| Arthritis Rheumatoid |
Associate |
35479077 |
| Autistic Disorder |
Associate |
26938441 |
| Breast Neoplasms |
Associate |
30191958, 30990809, 31253781, 33223203, 35966598 |
| Breast Neoplasms |
Stimulate |
31897900 |
| Carcinogenesis |
Associate |
36707804 |
| Carcinoma Hepatocellular |
Associate |
27656834, 32918976, 37581938 |
| Carcinoma Non Small Cell Lung |
Associate |
37548102 |
| Carcinoma Pancreatic Ductal |
Stimulate |
36271761 |
| Coloboma |
Associate |
36672956 |
| Colorectal Neoplasms |
Stimulate |
24948597 |
| COVID 19 |
Associate |
34670213 |
| Dementia |
Associate |
37328865 |
| Developmental Disabilities |
Inhibit |
27563068 |
| Developmental Disabilities |
Associate |
40225914 |
| Disease |
Associate |
26938441 |
| Dysentery Bacillary |
Associate |
28218003 |
| Escherichia coli Infections |
Associate |
17093030 |
| Eye Diseases |
Associate |
36672956 |
| Facial Dysmorphism with Multiple Malformations |
Associate |
40225914 |
| Glioblastoma |
Associate |
37974198 |
| Heart Defects Congenital |
Associate |
37000069 |
| Infections |
Associate |
17578910 |
| Inflammation |
Associate |
35479077, 37821650 |
| Intellectual Disability |
Associate |
40225914 |
| Language Development Disorders |
Associate |
40225914 |
| Leukemia |
Associate |
36450243, 37535603 |
| Leukemia Biphenotypic Acute |
Associate |
27563068 |
| Leukemia Myeloid Acute |
Inhibit |
27563068 |
| Leukemia Myeloid Acute |
Associate |
36450243 |
| Lung Neoplasms |
Associate |
34219384 |
| Lupus Erythematosus Systemic |
Associate |
27904655 |
| Mental Disorders |
Associate |
37000069, 40225914 |
| Microphthalmos |
Associate |
36672956 |
| Neoplasm Metastasis |
Associate |
30191958 |
| Neoplasms |
Inhibit |
27563068, 37581938 |
| Neoplasms |
Associate |
31253781, 31846841, 34219384, 36450243, 37735441, 37821650 |
| Neoplasms |
Stimulate |
32918976 |
| Obsessive Compulsive Disorder |
Associate |
31808517 |
| Oncogene Addiction |
Stimulate |
37581938 |
| Ovarian Neoplasms |
Associate |
36707804 |
| Parkinson Disease |
Associate |
28586827, 37328865 |
| Peters anomaly |
Associate |
36672956 |
| Pneumonia |
Associate |
37000069 |
| Prostatic Neoplasms |
Associate |
27268279, 33050986 |
| Schizophrenia |
Associate |
26938441, 29228394 |
| Sclerocornea |
Associate |
36672956 |
| Tracheal Stenosis |
Associate |
37000069 |
| Triple Negative Breast Neoplasms |
Associate |
30191958 |
|